alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
December 15, 2015 

### No. 14

- 15

- 00222

- CR
In the Court of Appeals for the

F ourteenth District of Texas, at Houston



Cause No

. 1072790

In the District Court for the 180th District Court, Harris County, Texas





### CLARENCE MATHIS

Appellant



### vs

. THE STATE OF TE XAS

Appellee



STATE’S WAIVER OF OPPORTUNITY TO
RESPOND TO APPELLANT’S ANDERS BRIEF



TO THE HONORABLE JUSTICES OF THE COURT OF APPEALS:

Comes now the State of Texas, by the undersigned assistant district attorney, and

respectfully waives the opportunity to file a brief in response to the Anders brief filed by the

appellant’s counsel. The State would respectfully show the Court the following:

I.

In keeping with the requirements of Anders v. California , 386 U.S. 738, 87 S.Ct.

1396 (1967), appointed counsel for the appellant has filed a brief containing the conclusion

that this appeal is frivolous. The appellant has been notified of his right to review the

appellate record and to file a pro se brief.

II.

A review of the appellant’s brie f reveals no question of constitutional dimension or

other issue requiring review in the interest of justice. ACCEPTED 14-15-00222-CR FOURTEENTH COURT OF APPEALS

HOUSTON, TEXAS 12/22/2015 3:37:25 PM CHRISTOPHER PRINE

CLERKDecember 15, 2015 III.

A copy of this instrument will be served on counsel for the appellant through

eFile.txcourts.gov

, on the date of the filing of this instrument with t he clerk of this court

.

THEREFORE , the State of Texas waives the opportunity to file a response to the

Anders brief filed by the appellant’s attorney, and moves the Court to affirm the trial court’s

judgment.

DEVON ANDERSON
District Attorne y Harris County, Texas

/s/ Alan Curry

ALAN CURRY Assistant District Attorney Harris County, Texas 1201 Franklin, Suite 600 Houston, Texas 77002 (713) 755

- 5826
TBC No. 05263700 curry_alan@dao.hctx.net
ARMED SERVICES BOARD OF CONTRACT APPEALS Appeals of

-- ) 

### ) URS Energy & Construction Inc. ) ) Under Contract Nos. FA8903-04-D-8680 ) FA3002-06-D-OOO I ) W9 I2ER-06-D-0006 ) APPEARANCE FOR THE APPELLANT:

APPEARANCES FOR THE GOVERNMENT: ASBCA Nos. 60796, 60797, 60798 60799,60800,60801

Nicole J. Owren-Wiest, Esq.

Crowell & Moring LLP Washington, DC E. Michael Chiaparas, Esq.

DCMA ChiefTrial Attorney Arthur M. Taylor, Esq.

Deputy ChiefTrial Attorney Defense Contract Management Agency Chantilly, VA ORDER OF DISMISSAL The dispute has been settled. The appeals are dismissed with prejudice. Dated: 3 May 2018

dmi 1strative Judge Chairman Armed Services Board of Contract Appeals
I certify that the foregoing is a true copy ofthe Order ofDismissal ofthe Armed Services Board ofContract Appeals in ASBCA Nos. 60796, 60797, 60798, 60799, 60800, 60801, Appeals ofURS Energy & Construction Inc., rendered in conformance with the Board's Charter. Dated: JEFFREY D. GARDIN Recorder, Armed Services Board ofContract Appeals
IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF TEXAS

DALLAS DIVISION

DERRICK HARRIS, 763436, )

Petitioner, )

)

v. ) No. 3:04-CV-800-N

) ECF

NATHANIEL QUARTERMAN, )

Director, TDCJ-CID, )

Respondent. )

ORDER

After making the review required by 28 U.S.C. § 636(b), the Court finds that the

Findings, Conclusions and Recommendation of the Magistrate Judge are correct, and they are

adopted as the findings and conclusions of the Court.

THEREFORE the Court finds that Petitioner mailed his notice of appeal on March 23,

2006.

Signed December 1, 2006.

_________________________________

DAVID C. GODBEY

UNITED STATES DISTRICT JUDGE

 

 Case 3:04-cv-00800-N Document 31 Filed 12/01/06 Page 1 of 1 PageID 90
Exhibit 12.1
     Year Ended December 31,2008


2007


2006


2005


2004Earnings (in thousands):Pre-tax income from continuing operations


45,906



30,442



13,373



17,815



6,053Fixed Charges


15,212



23,871



10,469



3,009



3,123Total earnings (deficiency)


61,118



54,313



23,842



20,824



9,176Fixed Charges (in thousands):Interest expense


8,108



13,618



6,781



460



776Amortization of expenses related to indebtedness


1,529



5,404



355



41



37Interest component of rent expense


5,575



4,849



3,333



2,508



2,310Total Fixed Charges


15,212



23,871



10,469



3,009



3,123Ratio of earnings to fixed charges


4.02



2.28



2.28



6.92



2.94
Case 3:04-cv-00986-M Document 13 Filed 01/19/06 Page 1 of 1 PageID 29
Exhibit 23.1



|                                                                                                                                                                                                          |  |                                                                                    
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  | -----------------------------------------------------------------------------------
|HANSEN, BARNETT & MAXWELL, P.C.
A Professional Corporation
CERTIFIED PUBLIC ACCOUNTANTS
5 Triad Center, Suite 750
Salt Lake City, UT 84180-1128
Phone: (801) 532-2200
Fax: (801) 532-7944
www.hbmcpas.com |  | Registered with the Public Company
Accounting Oversight Board


[exhibit231002.gif]









CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



To the Board of Directors

International Isotopes, Inc.



We consent to the use of our report dated March 31, 2010 with respect to the financial statements of International Isotopes, Inc. included in this annual report on Form 10-K filed on March 30, 2010 with the Securities Exchange Commission, and incorporated by reference in the Registration statements on Form S-8 (No. 333-121335, No. 333-108776, and 333-158575), and Form S-3 (No. 333-106215 and No. 333-142674).









HANSEN, BARNETT & MAXWELL, P.C.



Salt Lake City, Utah
March 31, 2010
EXHIBIT 32.2



CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Trade Street Residential,
Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2013, as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), I, Bert Lopez, Chief Financial Officer, certify, pursuant to 18 U.S.C.
§ 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, in my capacity as an officer of the
Company, that, to my knowledge:



| | 1. | The Report fully complies with the requirements of section 13(a)
                                                              or 15(d), as applicable, of the Securities Exchange Act of 1934;
                                                              and
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in
                                                              all material respects, the financial condition and results of operations
                                                              of the Company.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|Date: | June 13, 2013 | /s/ Bert
    Lopez                                 
|----- | ------------- | ---------------------------------------------------
|      |               | Bert Lopez                                         
|      |               | Chief Financial Officer and Chief Operating Officer
**Exhibit 99.7**

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Axcan Pharma Inc. (the “Company”) on Form 40-F for the period ending September 30, 2005 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dr. Frank A.G.M. Verwiel, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|----|-----------------------------------------------------------------------------------------------------------------------|
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------|

 

 
|   | /s/ Dr. Frank A.G.M. Verwiel           |
|--------|------------------------------------------------------------------------------------------|

Dr. Frank A.G.M. Verwiel

President and Chief Executive Officer

December 28, 2005

 

 

 

----
Exhibit 32

**CERTIFICATION PURSUANT TO**

**18 U.S.C.SECTION 1350**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of LYFE Communications, Inc., (the “Company”) on Form 10-Q for the period ending March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Gregory Smith, CEO and Garrett Daw, acting CFO of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
|  

 

 

 

 

*Date:*

*May 23, 2011*

 

*By:*

*/s/Gregory Smith*

 

 

 

 

*Gregory Smith,CEO*

 

 

 

 

 

*Date:*

*May 23, 2011*

 

 

*/s/Garrett Daw*

 

 

 

 

*Garrett Daw, acting CFO* |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
# C_2021028EN.01001201.xml

| 25.1.2021 | EN | Official Journal of the European Union | C 28/12 |
| --- | --- | --- | --- |

25.1.2021

EN

Official Journal of the European Union

C 28/12

---

Request for a preliminary ruling from the Consiglio di Stato (Italy) lodged on 28 September 2020 — Cirsa Italia SpA v Agenzia delle Dogane e dei Monopoli

(Case C-476/20)

(2021/C 28/17)

Language of the case: Italian

Referring court

Consiglio di Stato

Parties to the main proceedings

Appellant: Cirsa Italia SpA

Respondent: Agenzia delle Dogane e dei Monopoli

Questions referred

| 1. | Is the introduction of a provision, such as that contained in Article 1(649) of Law 190/14, which reduces commission and fees only in respect of a specific and limited category of operator, namely operators of games played on gaming machines, and not all operators in the gaming sector, compatible with the exercise of the freedom of establishment guaranteed by Article 49 TFEU and with the exercise of the freedom to provide services guaranteed by Article 56 TFEU? |
| --- | --- |

1.

Is the introduction of a provision, such as that contained in Article 1(649) of Law 190/14, which reduces commission and fees only in respect of a specific and limited category of operator, namely operators of games played on gaming machines, and not all operators in the gaming sector, compatible with the exercise of the freedom of establishment guaranteed by Article 49 TFEU and with the exercise of the freedom to provide services guaranteed by Article 56 TFEU?

| 2. | Is the introduction of the abovementioned provision contained in Article 1(649) of Law 190/14, which for economic reasons alone reduced the fees agreed to in a concession agreement concluded between a company and an Italian State authority during the term of that agreement, compatible with the EU-law principle of the protection of legitimate expectations? |
| --- | --- |

2.

Is the introduction of the abovementioned provision contained in Article 1(649) of Law 190/14, which for economic reasons alone reduced the fees agreed to in a concession agreement concluded between a company and an Italian State authority during the term of that agreement, compatible with the EU-law principle of the protection of legitimate expectations?

---
Exhibit 13.2


Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002




Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of EXFO Inc., hereby certifies, that:




1.
The Annual Report on Form 20-F for the year ended August 31, 2013 of EXFO fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and




2.
The information contained in this Annual Report fairly presents, in all material respects, the financial condition and results of operations of EXFO.




Date:           November 25, 2013










/s/Pierre Plamondon


Pierre Plamondon, CPA, CA


Vice-President, Finance


and Chief Financial Officer


(Principal Financial Officer)





The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the Report or as separate disclosure document.
#### The Fidelity & Casualty Company of New York, a Corporation of the State of New York, *Appellant,*v. Mary Elizabeth Long and Harold B. Long, Her Husband, *Appellees.*

Division B.

Opinion Filed August 1, 1927.

*Huber, Clements & Blackwell,*Attorneys for Appellant;

*M. D. Carmichael*and *Ernest Metcalf,*Attorneys for Appellees.

*548Buford, J.

In this case demurrer was sustained to an amended declaration and, the plaintiff declining to plead further, order of court was entered dismissing the cause, to which order writ of error was taken.

The declaration attempts to allege a cause of action based upon promissory notes and a contract executed by a married woman in the State of Florida, which notes and contract were so executed by her in consideration of the extiuguishment of certain obligations which she executed in the State of New York.

It appears that the obligation alleged to have been so satisfied and extinguished was valid and binding under the laws of the State of New York. See Sec. 51, Article 4 of the Domestic Relation Law of the State of New York. But, when the plaintiff’s assignor accepted in lieu of that obligation the contract and notes executed in Florida by a married woman then residing in Florida, and which notes were made payable at a bank in Florida, it accepted an obligation which could not form the basis of a common law action in this State, because the notes so executed by such married woman are void and the allegation of the declaration establish this state of facts.

The order sustaining the demurrer to the amended declaration and dismissing the cause should be affirmed on authority of the opinion in the cases of Hodges v. Price, 18 Fla. 342; Virginia-Carolina Chemical Co. v. Fisher et al., 58 Fla. 377, 50 Sou. 504, and it is so ordered.

Affirmed.

Whitfield, P. J., and Terrell, J., concur.

Ellis,' C. J., and Strum; and Brown, J. J., concur in the opinion.
Exhibit 32 CERTIFICATION PURSUANT TO 18 U.S.C.SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Quarterly Report of LYFE Communications, Inc., (the Company) on Form 10-Q for the period ending June 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Robert A. Bryson, President and acting CFO of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002:  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.   Date:August 23, 2010By:/s/Robert A. BrysonRobert A. Bryson, President and acting CFO
```

[Federal Register Volume 90, Number 7 (Monday, January 13, 2025)]
[Notices]
[Page 2710]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-00455]

[[Page 2710]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Mechanistic Studies to Investigate the 
Interrelationship Between Sleep and/or Circadian Rhythms and 
Substance Use Disorders.
    Date: February 21, 2025.
    Time: 10:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institute of Health, National Institute on 
Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Ipolia R. Ramadan, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, 
MSC 6021, Bethesda, MD 20892, (301) 827-4471, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Interplay of Autophagy Regulated Cell Death and HIV 
Pathogenesis in Substance Use Disorders and Research on the Neuro-
Immune Axis in the Context of HIV and Substance Use.
    Date: February 24, 2025.
    Time: 11:00 a.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institute of Health, National Institute on 
Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Meysam Yazdankhah, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Institute on Drug Abuse, 
NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, 
(301) 402-6965, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse and Addiction Research Programs, National 
Institutes of Health, HHS)

    Dated: January 6, 2025.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-00455 Filed 1-10-25; 8:45 am]
BILLING CODE 4140-01-P
```
Case 3:04-cv-02524-M Document 10 Filed 06/01/05 Page 1 of 1 PageID 39
SIDE
LETTER 


  


	INTEGUMEN
                                         LIMITED

        
	 
	Sand
    Hutton Applied Innovation Campus	 
	Sand
    Hutton	 
	York	 
	North
    Yorkshire	 
	YO41
    1LZ	 
	England	 
	 	 
	ENHANCE
    SKIN PRODUCTS INC	 
	50
    West Liberty Street	 
	Suite
    880	 
	Reno	 
	NV
    89501	 
	United
    States of America 	 


 


29
September 2016


 


	Re
    	Enhance
    Skin Products Inc. (the “Company”)


 


Dear
Sirs


 


We
refer to the option agreement, dated 7 July 2016, between (1) Integumen Limited, formally known as BioSurface Limited (“Integumen”)
and (2) the Company (the “Option Agreement”). This letter constitutes a side letter to the Option Agreement.


 


Save
as otherwise provided for in this letter, defined terms used in this letter shall have the meaning ascribed to such terms in the
Option Agreement.


 


We
the undersigned being all of the parties to the Option Agreement hereby agree and confirm that, in consideration for the participation
by each party hereto in the good faith negotiations in relation to the entry into an asset purchase agreement in relation to certain
assets owned by the Company, the Option Agreement shall be amended, in accordance with Clause 10.3 of the Option Agreement, by
the deletion of the current Clause 3.2 of the Option Agreement and its replacement with the following new Clause 3.2:


 


“3.2
The Option shall lapse on 30 September 2016.”


 




    	 



    	 		 



    

 


This
letter may be executed in any number of counterparts each of which when executed and delivered shall be an original, but all the
counterparts together shall constitute one and the same instrument.


 


This
letter shall be governed by the laws of England and Wales and the parties hereby irrevocably submit to the jurisdiction of the
courts of England and Wales in relation to any dispute arising from, or in connection with, this letter.


 


Yours
faithfully


 


	 	 	 
	Duly
    authorised, for and on behalf of 	 	Duly
    authorised, for and on behalf of 
	INTEGUMEN
                                         LIMITED

        
	 	ENHANCE
    SKIN PRODUCTS INC.
### I N THE UNI TED STATES COURT OF APPEALS FOR THE FI F TH CI RCUI T

No. 12-41378 Summary Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee

v. HERIBERTO MENDEZ-ALVAREZ, Defendant-Appellant

A ppeal from the United States District Court for the Southern District of Texas USDC No. 7:12-CR-1168-1

Before HIGGINBOTHAM, DENNIS, and GRAVES, Circuit Judges. PER CURIAM: * The Federal Public Defender appointed to represent Heriberto MendezAlvarez has moved for leave to withdraw a nd has filed a brief in a ccordance with Anders v. C

alifornia , 386 U.S. 738 (1967), and United S tates v. Flores , 632 F.3d 229 (5th Cir. 2011). Mendez-Alvarez has not filed a response. We have r eviewed counsel’s brief a nd t h e r elevant portions o f the record r eflected t h erein. We

concur with counsel’s assessment that the a ppeal presents no n onfrivolous issue for appellate revi e w . A c c o rdingly, counsel’s motion for leave t o withdraw is GRANTED, coun s e l i s excused from further responsibilities herein, and the APPEAL IS DISMISSED. See 5 T H C I R
. R. 42.2. U n i t e d S t a te s C o u r t o f A p p e al s F i f t h C i rc u i t 

### F I L E D Decem ber 11, 2013 Ly l e W . Cay ce Clerk

* Purs uant to 5 T H C I R

. R

. 47. 5, the court has d eterm ined that this op inion should not be p ublis hed and is not p reced ent excep t und er the lim ited circum s tances s et forth in 5 T H C I R

. R. 47. 5. 4. Case: 12-41378 Document: 00512467671 Page: 1 Date Filed: 12/11/2013
Frederick STRAIN, Appellant, v. STATE of Florida, Appellee.

No. 1D18-3864

District Court of Appeal of Florida, First District.

February 21, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.